Literature DB >> 10993060

Alzheimer's disease. A partner for presenilin.

D Schenk.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10993060     DOI: 10.1038/35024194

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

1.  Metalloproteases regulate T-cell proliferation and effector function via LAG-3.

Authors:  Nianyu Li; Yao Wang; Karen Forbes; Kate M Vignali; Bret S Heale; Paul Saftig; Dieter Hartmann; Roy A Black; John J Rossi; Carl P Blobel; Peter J Dempsey; Creg J Workman; Dario A A Vignali
Journal:  EMBO J       Date:  2007-01-24       Impact factor: 11.598

Review 2.  Intracellular cholesterol and phospholipid trafficking: comparable mechanisms in macrophages and neuronal cells.

Authors:  G Schmitz; E Orsó
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

Review 3.  Alzheimer's disease--a dysfunction in cholesterol and lipid metabolism.

Authors:  Walter J Lukiw; Miguel Pappolla; Ricardo Palacios Pelaez; Nicolas G Bazan
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

4.  Cardiovascular dementia - a different perspective.

Authors:  Udhaya Kumari; Klaus Heese
Journal:  Open Biochem J       Date:  2010-03-26

5.  Interactome analyses of mature γ-secretase complexes reveal distinct molecular environments of presenilin (PS) paralogs and preferential binding of signal peptide peptidase to PS2.

Authors:  Amy Hye Won Jeon; Christopher Böhm; Fusheng Chen; Hairu Huo; Xueying Ruan; Carl He Ren; Keith Ho; Seema Qamar; Paul M Mathews; Paul E Fraser; Howard T J Mount; Peter St George-Hyslop; Gerold Schmitt-Ulms
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

6.  Binding of HSV-1 glycoprotein K (gK) to signal peptide peptidase (SPP) is required for virus infectivity.

Authors:  Sariah J Allen; Kevin R Mott; Yoshiharu Matsuura; Kohji Moriishi; Konstantin G Kousoulas; Homayon Ghiasi
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.